Well I continue to contact the company but no luck yet in actually talking to anyone. I'm just trying to confirm the timing of the HBV data and some other questions as I missed the conference call.
In relation to J8's point about finding patients, remember what West said in the December release - "the HCV trial is now on schedule".
Two months later they cannot get any patients to proceed. So it all changed in two months? Possible as it did however take 3 months to find the second cohort 4 patient. However his two statements are contradictions.
They have 'locked up the data' till Q4 but must have some initial data from Cohort 4 as it has been 3 months since the first dose. At least they have two patients dosed which will provide some validation to the data.
The future of the company is
positive hep B in vivo data
positive TT-034 data
partner or buy out
Apart from negative data can anyone an alternative path?
Well I continue to contact the company but no luck yet in...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)